The subcutaneous administration of the vasopressin analogue 1-desamino-8-D-arginine vasopressin in patients with von Willebrand's disease and hemophilia

This publication has 31 references indexed in Scilit:

• The Effect of Intranasal DDAVP on Coagulation and Fibrinolytic Activity in Normal Persons
  Scandinavian Journal of Haematology, 2009
• RESPONSE OF FACTOR XII TO DDAVP IN PATIENTS WITH HAGEMAN FACTOR DEFICIENCY
  British Journal of Haematology, 1983
• DDAVP: A useful alternative to blood components in moderate hemophilia A and von Willebrand disease
  The Journal of Pediatrics, 1983
• Socioeconomic Evaluation of a State-Funded Comprehensive Hemophilia-Care Program
  New England Journal of Medicine, 1982
• Additional factor XII (hageman factor) deficiency in hemophilia a and in von willebrand syndrome
  Journal of Molecular Medicine, 1982
• Acute Hepatitis Non-A, Non-B following Administration of Factor VIII Concentrates
  Vox Sanguinis, 1981
• The Release of Plasminogen Activator and Factor VIII after Injection of DDAVP in Healthy Volunteers and in Patients with von Willebrand's Disease
  Scandinavian Journal of Haematology, 1980
• Standardization of Factor VIII I. CALIBRATION OF BRITISH STANDARDS FOR FACTOR VIII CLOTTING ACTIVITY
  British Journal of Haematology, 1980
• D.D.A.V.P. IN HÆMOPHILIA
  The Lancet, 1977
• VON WILLEBRAND DISEASE SAN DIEGO, A NEW VARIANT
  The Lancet, 1976